Related Experiment Videos
The establishment of MDMS-resistant cloned cell lines from in vitro cultured, MDMS-sensitive, Yoshida sarcoma cells
Chemico-Biological Interactions
|January 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Epithelial cell, keratocyte, and endothelial cell apoptosis in Fuchs dystrophy and in pseudophakic bullous keratopathy.
European journal of ophthalmology·2017
R-deprenyl: pharmacological spectrum of its activity.
Neurochemical research·2010
Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.
Journal of neural transmission (Vienna, Austria : 1996)·2010
Effect of formaldehyde and resveratrol on the viability of Vero, HepG2 and MCF-7 cells.
Cell biology international·2007
Cell proliferation and apoptosis in stromal corneal dystrophies.
Histology and histopathology·2007
Effect of Avemar--a fermented wheat germ extract--on rheumatoid arthritis. Preliminary data.
Clinical and experimental rheumatology·2006
Polylactic acid nanoplastics induce kidney injury by activating the TRPM2-mediated mitophagy pathway.
Chemico-biological interactions·2026
Maternal CuO NPs exposure induces vascular damage in offspring via ferroptosis and cuproptosis: the regulatory role of GSH.
Chemico-biological interactions·2026
Re-examination of Hermann J. Muller's 1927 Nobel Prize research: The ClB model validity, the Mavor precedent, and the reverse mutation mirage.
Chemico-biological interactions·2026
Senomorphic miR-3155b suppresses the senescence-associated secretory phenotype in therapy-induced senescence.
Frontiers in cell and developmental biology·2026
Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?
Frontiers in pharmacology·2026
Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies.
Frontiers in immunology·2026
Profiling crystal engineered ligands for targeting treatment resistant androgen receptors.
Frontiers in pharmacology·2026